Evidence map›Paper›PMID 38225631›Full record

ArticleGenome biology2024

ARMC5 controls the degradation of most Pol II subunits, and ARMC5 mutation increases neural tube defect risks in mice and humans.

Hongyu Luo, Linjiang Lao, Kit Sing Au, Hope Northrup, Xiao He, Diane Forget, Marie-Soleil Gauthier, Benoit Coulombe, Isabelle Bourdeau, Wei Shi and 4 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. CRL3Molecular cell · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Hongyu Luo *Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. hongyu.luo@umontreal.ca.
Linjiang Lao *Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Kit Sing AuDepartment of Pediatrics, McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth) and Children's Memorial Hermann Hospital, Houston, TX, USA.
Hope NorthrupDepartment of Pediatrics, McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth) and Children's Memorial Hermann Hospital, Houston, TX, USA.
Xiao HeCentre de Recherche, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Diane ForgetDepartment of Translational Proteomics, Institut de Recherches Cliniques de Montréal, Montreal, QC, Canada.
Marie-Soleil GauthierDepartment of Translational Proteomics, Institut de Recherches Cliniques de Montréal, Montreal, QC, Canada.
Benoit CoulombeDepartment of Translational Proteomics, Institut de Recherches Cliniques de Montréal, Montreal, QC, Canada.
Isabelle BourdeauCentre de Recherche, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Wei ShiCentre de Recherche, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Lucia GagliardiAdelaide Medical School, University of Adelaide, Adelaide, Australia.
Maria Candida Barisson Villares FragosoUnidade de Suprarrenal Disciplina de Endocrinologia E Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Junzheng PengCentre de Recherche, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Jiangping WuCentre de Recherche, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada. jianping.wu@umontreal.ca.ORCID 0000-0001-5605-2334
Centre Hospitalier de l’Université de Montréal · CAMontreal Clinical Research Institute · CAMemorial Hermann · USHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRSouth Australia Pathology · AU

Funding

Creating a Myelomeningocele Exome Variant MapR01HD073434 · NICHD · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI AU, KIT SING · 2014 to 2018
$2.4M
Institute of Musculoskeletal Health and Arthritis PJT-180284Natural Sciences and Engineering Research Council of Canada RGPIN-2017-04790NICHD NIH HHS R01 HD073434
6 · The paper itself

Abstract

backgroundNeural tube defects (NTDs) are caused by genetic and environmental factors. ARMC5 is part of a novel ubiquitin ligase specific for POLR2A, the largest subunit of RNA polymerase II (Pol II).

resultsWe find that ARMC5 knockout mice have increased incidence of NTDs, such as spina bifida and exencephaly. Surprisingly, the absence of ARMC5 causes the accumulation of not only POLR2A but also most of the other 11 Pol II subunits, indicating that the degradation of the whole Pol II complex is compromised. The enlarged Pol II pool does not lead to generalized Pol II stalling or a generalized decrease in mRNA transcription. In neural progenitor cells, ARMC5 knockout only dysregulates 106 genes, some of which are known to be involved in neural tube development. FOLH1, critical in folate uptake and hence neural tube development, is downregulated in the knockout intestine. We also identify nine deleterious mutations in the ARMC5 gene in 511 patients with myelomeningocele, a severe form of spina bifida. These mutations impair the interaction between ARMC5 and Pol II and reduce Pol II ubiquitination.

conclusionsMutations in ARMC5 increase the risk of NTDs in mice and humans. ARMC5 is part of an E3 controlling the degradation of all 12 subunits of Pol II under physiological conditions. The Pol II pool size might have effects on NTD pathogenesis, and some of the effects might be via the downregulation of FOLH1. Additional mechanistic work is needed to establish the causal effect of the findings on NTD pathogenesis.

Indexed as

Armadillo Domain ProteinsNeural Tube DefectsSpinal DysraphismAnimalsFolic AcidHumansMiceMice, KnockoutMutationArmadillo Domain ProteinsARMC5 protein, humanArmc5 protein, mouseFolic AcidARMC5FOLH1MyelomeningoceleNeural tube defectsPol II pool sizeUbiquitin ligase specific for all Pol II subunits

Identifiers

PMID38225631
PMCPMC10789052
OpenAlexW4390885600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.